The Creatine Brain Benefits That Science Can, and Cannot, Confirm.

The molecule that built a $14 billion sports supplement industry has been quietly auditioning for a second career. Creatine, the same compound that gym culture associated with bigger muscles and heavier lifts, is now the subject of more than 680 clinical trials investigating whether it can do for the brain what it demonstrably does for skeletal muscle: buffer the energy supply when demand outstrips delivery.^[13] The premise is plausible. The brain accounts for roughly 20% of the body's total energy consumption despite representing just 2% of its mass.^[18] Adenosine triphosphate (ATP) is required for every action potential, every synaptic transmission, every moment of sustained attention, and neurons burn through it at a rate of approximately 4.7 billion molecules per second per cortical neuron.^[6] If creatine can even marginally improve ATP availability in neural tissue, the cognitive implications would be significant.

That "if" carries more weight than most supplement marketing acknowledges. The evidence that has accumulated since Caroline Rae's 2003 vegetarian trial is genuinely interesting, and genuinely incomplete.^[22] Two independent meta-analyses report memory improvements in older adults.^[27][21] A neuroimaging study captured real-time brain energy changes after a single dose.^[10] A large epidemiological survey found a striking association between dietary creatine and depression prevalence.^[3] Together, these findings suggest creatine does something in the brain. The question this article examines is what, exactly, and for whom.

The answer, as the best evidence currently frames it, is conditional. Creatine brain benefits appear concentrated in populations whose phosphocreatine reserves are already depleted: by age, by dietary restriction, by sleep deprivation, or by clinical pathology.^[23] In healthy young adults eating a normal diet and sleeping well, the two largest independent trials found essentially nothing.^[23][19] That pattern is not a failure of creatine research. It is the research's most important finding.

The trajectory of creatine brain benefits research follows a pattern familiar in nutritional neuroscience: an early striking finding, a wave of enthusiasm, then a slow, uncomfortable correction toward nuance. Rae's 2003 crossover trial in vegetarians showed improvements in working memory and fluid intelligence so pronounced (p < 0.0001) that it became the founding citation for an entire research programme.^[22] The logic was clean: vegetarians have lower baseline brain creatine because they consume almost none through diet; supplementing restores what diet withholds; cognition improves. The dietary gap hypothesis was born.

What followed was a decade of studies attempting to extend that finding to the general population. Some showed benefits; many did not. A 2025 article in the Journal of Nutrition documented what had become obvious to field insiders: "public enthusiasm and commercial promotion have far exceeded the strength of the supporting evidence." The gap between what creatine demonstrably does in the brain and what the supplement industry implies it does has become one of the more useful case studies in the translation problem, the distance between a promising mechanistic hypothesis and a justified health claim.

This article does not settle that translation problem. It ranks the evidence, names the uncertainties, and identifies the specific conditions under which creatine brain benefits have survived rigorous testing. The answer is narrower than the headlines suggest, and more interesting.

Every neuron in the cerebral cortex is, at its most basic level, an energy management problem. The brain's primary currency is ATP, and the demand is relentless. Firing rates fluctuate, but the baseline metabolic cost of maintaining neuronal membrane potentials alone consumes roughly two-thirds of the brain's total energy budget.^[6] When a neuron fires, ATP expenditure spikes. When it engages in sustained cognitive effort, holding information in working memory or suppressing a prepotent response, the local demand can outstrip the supply rate from oxidative phosphorylation, the primary ATP production pathway.^[4] This is where creatine enters the story.

The phosphocreatine system operates as a temporal bridge. When ATP supply exceeds immediate demand, the enzyme creatine kinase transfers a phosphate group from ATP to free creatine, storing it as phosphocreatine. When demand surges, the reaction runs in reverse: phosphocreatine donates its phosphate back to adenosine diphosphate (ADP), regenerating ATP within milliseconds.^[29] The reaction is orders of magnitude faster than oxidative phosphorylation. In muscle physiology, this is the system that powers the first 8–10 seconds of a sprint; in neural tissue, it buffers transient energy shortfalls during periods of high cognitive demand.^[1]

The body synthesises roughly 1–2 grams of creatine daily in the liver and kidneys, and an omnivorous diet supplies another 1–2 grams through meat and fish.^[4] Vegetarians and vegans consume essentially none through diet, making them dependent on endogenous synthesis alone. That detail will matter when we reach the evidence.

That buffering function only matters if the buffer can be filled. In muscle, this is straightforward. Creatine crosses capillary walls by passive diffusion and active transport, and muscle tissue absorbs it readily: supplementation increases intramuscular creatine stores by 20–30% within days.^[29] The brain faces a different logistics problem. The blood-brain barrier does not permit passive creatine entry. Instead, creatine must be actively transported through a dedicated carrier protein, the SLC6A8 transporter, embedded in the endothelial cells lining cerebral capillaries.^[5][24]

This transporter is the rate-limiting step in the entire creatine brain benefits story. Its expression is tightly regulated, and its capacity appears to saturate at relatively low concentrations. When Forbes and colleagues reviewed 12 human magnetic resonance spectroscopy (MRS) studies measuring brain creatine after oral supplementation, they found increases ranging from 3% to 10%, with a typical value around 6%.^[9] Lyoo's 2003 31P-MRS study, using a loading protocol of 0.3 g/kg per day, measured frontal lobe increases of 8.1–9.3%.^[15] Kondo's dose-ranging study in adolescent females with treatment-resistant depression found a 9.1% increase in frontal phosphocreatine at 10 g/day.^[12]

The brain also synthesises creatine locally. Neurons and oligodendrocytes express the enzymes AGAT and GAMT, which catalyse the two-step synthesis of creatine from arginine, glycine, and methionine.^[30] This local production supplements, but does not replace, transport from the bloodstream. The relative contributions of local synthesis versus transport remain uncertain, though mutations in SLC6A8 that abolish transport produce severe cerebral creatine deficiency with profound intellectual disability, indicating that transport is indispensable.^[25]